Cadila Healthcare informs about press release

01 Sep 2017 Evaluate

Cadila Healthcare has informed about the press release titled ‘Zydus receives final approval from the USFDA for Donepezil Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

920.45 -0.80 (-0.09%)
16-Dec-2025 11:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.30
Dr. Reddys Lab 1275.95
Cipla 1505.00
Zydus Lifesciences 920.45
Lupin 2087.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×